4/A//SEC Filing
Smith Christopher M 4/A
Accession 0001077183-24-000168
CIK 0001077183other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:09 PM ET
Size
9.4 KB
Accession
0001077183-24-000168
Insider Transaction Report
Form 4/AAmended
Smith Christopher M
Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-11+48,063→ 650,282 total - Tax Payment
Common Stock
2024-05-11$14.86/sh−18,913$281,047→ 631,369 total - Exercise/Conversion
Restricted Stock Unit
2024-05-11−48,063→ 96,127 totalExercise: $0.00→ Common Stock (48,063 underlying)
Footnotes (5)
- [F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
- [F2]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
- [F3]On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 631,369 shares of common stock after the vesting of 48,063 RSUs and reported withholding. The error effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4.
- [F4]On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three year anniversary dates of the grant date.
- [F5]Once vested, the shares of common stock are not subject to expiration.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001436707
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:09 PM ET
- Size
- 9.4 KB